Skip to main content
. 2020 Feb 19;21(4):1391. doi: 10.3390/ijms21041391
ACS Acute coronary syndrome
ADP Adenosine diphosphate
ALI Acute lung injury
APC Antigen-presenting cells
ApoE Apolipoprotein E
ARDS Acute respiratory distress syndrome
ATP Adenosine triphosphate
CAD Coronary artery disease
cAMP Cyclic adenosine monophosphate
CD40 Cluster of differentiation 40
COX Cyclooxygenase
CREKA Tumor-homing peptide Cys-Arg-Glu-Lys-Ala
CRP C-reactive protein
CYP450 Cytochrome P450
DC Dendritic cells
EL Extracellular loop
ENT-1 Equilibrative nucleoside transporter 1
FDA Food and Drug Administration
Gi G-protein i
G-protein Guanine nucleotide-binding protein
Gq G-protein q
GPIIbIIIa Glycoprotein αIIbβ3
HMGB1 High-mobility group box 1
IL Interleukin
IP3 Inositol 1,4,5-trisphosphate
LPS Lipopolysaccharide
MACE Major adverse cardiovascular event
MCP-1 Monocyte chemoattractant protein 1
NETs Neutrophil extracellular traps
PAR Protease-activated receptors
PCI Percutaneous coronary intervention
PDGF Platelet-derived growth factor
PF4 Platelet factor 4
PI3K Phosphoinositide-3-kinase
PKA Protein kinase A
PLAs Platelet leukocyte aggregates
RANTES Regulated on activation, normal T-cell-expressed and -secreted
ROS Reactive oxygen species
TCIPA Tumor-cell-induced platelet activation
TF Tissue factor
TGF Transforming growth factor
TME Tumor microenvironment
TNF Tumor necrosis factor
TXA2 Thromboxane A2
VASP Vasodilator-stimulated phosphoprotein
VEGF Vascular endothelial growth factor
VSCMs Vascular smooth muscle cells